-The Indian Express Data shows that the state is high on growth, low on development. What does this say about the government's priorities? No matter what the political leanings, many people have come to accept the premise that Gujarat has performed a lot better than the rest of India in terms of development over the last decade. People are even talking about the Gujarat model of development as something for the whole...
More »SEARCH RESULT
Funds dry up for drug discovery project -Rema Nagarajan
-The Times of India Funding for one of the foremost drug discovery projects in India came to an end on Monday as the financial year closed because the ministry of science and technology did not clear the cabinet note meant to extend funding for the project on time. The Open Source Drug Discovery (OSDD) project of the Council of Scientific and Industrial Research (CSIR), meant to discover drugs for neglected diseases, had...
More »Government not doing a great job of generating more jobs -Sanjoy Narayan
-The Hindustan Times If you've somehow managed to wrench yourself away from witnessing the ever plunging new lows during the ongoing election campaigns, including name calling, mud (and ink) slinging and repeated exchanges of the same accusations between political rivals, you will surely have noticed the exuberance in the markets - the Sensex has touched a record high and the long-languishing rupee has strengthened to within striking distance of sub-Rs 60...
More »UPA is not able to take credit for what it has done -Abhijit Banerjee
-The Hindustan Times We are a nation holding our breath. Some in eager anticipation, others in ambiguous apprehension or actual terror, but all of us transfixed by the drama of Mr Narendra Modi's arrival. Even those who do not relish the thought of the outcome seem happy to get it over, to put behind us this sad drama of the UPA's strange implosion, the decline, Lear-like, from decisiveness (if wrong-headed at times)...
More »Friction over drug patents
-The Hindu Differences over intellectual property rights (IPRs) have emerged as a strong undercurrent in India's economic relations with the U.S. The attempt by the influential pharmaceutical lobby to stymie India's efforts to ensure the supply of medicines at affordable rates without violating existing treaty commitments, requires a principled response from New Delhi. At the core of the issue is what Columbia University Professor Arvind Panagariya calls "the hijacking of...
More »